Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Chronic Treatment With Losartan Results in Sufficient Serum Levels of the Metabolite EXP3179 for PPAR Activation
Hypertension, 08/25/09
Kappert K et al. – The data show that sufficient serum levels of EXP3179 are present under losartan treatment. PPAR activation by AT1R–blockers may translate into synergistic beneficial actions in monocytes.
Related Articles
Efficacy and Safety of Losartan in Treatment of Hyperuricemia and Posttransplantation Erythrocytosis: Results of a Prospective, Open, Randomized, Case-Control Study
Transplantation Proceedings, 11/20/09
Relevance Score: 87%
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The Lancet - Early Online Publication, 11/18/09
Relevance Score: 87%
Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis
Atherosclerosis, 11/13/09
Relevance Score: 87%
Recoverability of Renal Function After Relief of Chronic Partial Unilateral Ureteral Obstruction: Study of the Effect of Angiotensin Receptor Blocker (Losartan)
Urology, 10/28/09
Relevance Score: 87%
Loeys-Dietz syndrome: a Marfan-like syndrome associated with aggressive vasculopathy
Singapore Medical Journal, 11/11/09
Relevance Score: 84%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of coenzyme Q10 in cardiac disease, hypertension and Meniere-like syndrome
Pharmacology & Therapeutics, 12/17/09
Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic
Hypertension Research, 12/17/09
A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study
Hypertension Research, 12/17/09
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Hibiscus Sabdariffa L. Tea (Tisane) Lowers Blood Pressure in Prehypertensive and Mildly Hypertensive Adults
The Journal of Nutrition, 12/17/09
Role of coenzyme Q10 in cardiac disease, hypertension and Meniere-like syndrome
Pharmacology & Therapeutics, 12/17/09
Late-Onset Pulmonary Arterial Hypertension After a Successful Atrial or Arterial Switch Procedure for Transposition of the Great Arteries
Pediatric Cardiology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


